Gender differences in insulin resistance, body composition, and energy balance

Gender Medicine

Volumn 6, Issue SUPPL. 1, 2009, Pages 60-75

  Geer, Eliza B ^a   Shen, Wei ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

body composition; energy balance; fat distribution; gender; insulin; visceral adipose tissue

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; ESTROGEN; FATTY ACID; GHRELIN; GLUCOSE; INSULIN; LEPTIN; PRASTERONE; SEX HORMONE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ANTHROPOMETRY; ARTICLE; BODY COMPOSITION; BODY FAT; BODY MASS; ENERGY BALANCE; ENERGY EXPENDITURE; FATTY LIVER; FEMALE; FOOD INTAKE; HORMONE RELEASE; HUMAN; INDIVIDUALIZATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; LEAN BODY WEIGHT; MALE; MEDICAL RESEARCH; MEDLINE; METABOLIC RATE; NONHUMAN; OBESITY; PATIENT CARE; PRIORITY JOURNAL; REST; SEX DIFFERENCE; SUBCUTANEOUS FAT;

BODY COMPOSITION; DEHYDROEPIANDROSTERONE; ENERGY INTAKE; ENERGY METABOLISM; ESTROGENS; FEMALE; HUMANS; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; MALE; REFERENCE VALUES; SEX CHARACTERISTICS; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE;

EID: 62649165515     PISSN: 15508579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.genm.2009.02.002     Document Type: Article

References (156)

1. Moller D.E., and Flier J.S. Insulin resistance-mechanisms, syndromes, and implications. N Engl J Med 325 (1991) 938-948
2. Kershaw E.E., and Flier J.S. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89 (2004) 2548-2556
3. Eckel R.H., Kahn R., Robertson R.M., and Rizza R.A. Preventing cardiovascular disease and diabetes: A call to action from the American Diabetes Association and the American Heart Association. Circulation 113 (2006) 2943-2946
4. Kissebah A.H., Vydelingum N., Murray R., et al. Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab 54 (1982) 254-260
5. Sparrow D., Borkan G.A., Gerzof S.G., et al. Relationship of fat distribution to glucose tolerance. Results of computed tomography in male participants of the Normative Aging Study. Diabetes 35 (1986) 411-415
6. Fujioka S., Matsuzawa Y., Tokunaga K., and Tarui S. Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism 36 (1987) 54-59
7. Despres J.P., Nadeau A., Tremblay A., et al. Role of deep abdominal fat in the association between regional adipose tissue distribution and glucose tolerance in obese women. Diabetes 38 (1989) 304-309
8. Lundgren H., Bengtsson C., Blohme G., et al. Adiposity and adipose tissue distribution in relation to incidence of diabetes in women: Results from a prospective population study in Gothenburg, Sweden. Int J Obes 13 (1989) 413-423
9. Carey V.J., Walters E.E., Colditz G.A., et al. Body fat distribution and risk of non-insulin-dependent diabetes mellitus in women. The Nurses' Health Study. Am J Epidemiol 145 (1997) 614-619
10. Wei M., Gaskill S.P., Haffner S.M., and Stern M.P. Waist circumference as the best predictor of noninsulin dependent diabetes mellitus (NIDDM) compared to body mass index, waist/hip ratio and other anthropometric measurements in Mexican Americans-a 7-year prospective study. Obes Res 5 (1997) 16-23
11. Kaye S.A., Folsom A.R., Sprafka J.M., et al. Increased incidence of diabetes mellitus in relation to abdominal adiposity in older women. J Clin Epidemiol 44 (1991) 329-334
12. Chan J.M., Rimm E.B., Colditz G.A., et al. Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care 17 (1994) 961-969
13. Wang Y., Rimm E.B., Stampfer M.J., et al. Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. Am J Clin Nutr 81 (2005) 555-563
14. Kotani K., Tokunaga K., Fujioka S., et al. Sexual dimorphism of age-related changes in whole-body fat distribution in the obese. Int J Obes Relat Metab Disord 18 (1994) 207-212
15. Relationship of body size and shape to the development of diabetes in the diabetes prevention program. Obesity (Silver Spring) 14 (2006) 2107-2117
16. Garaulet M., Perex-Llamas F., Fuente T., et al. Anthropometric, computed tomography and fat cell data in an obese population: Relationship with insulin, leptin, tumor necrosis factor-alpha, sex hormone-binding globulin and sex hormones. Eur J Endocrinol 143 (2000) 657-666
17. Garaulet M., Hernandez-Morante J.J., Lujan J., et al. Relationship between fat cell size and number and fatty acid composition in adipose tissue from different fat depots in overweight/obese humans. Int J Obes (Lond) 30 (2006) 899-905
18. Wajchenberg B.L. Subcutaneous and visceral adipose tissue: Their relation to the metabolic syndrome. Endocr Rev 21 (2000) 697-738
19. Bjorntorp P. The regulation of adipose tissue distribution in humans. Int J Obes Relat Metab Disord 20 (1996) 291-302
20. Ritchie S.A., and Connell J.M. The link between abdominal obesity, metabolic syndrome and cardiovascular disease. Nutr Metab Cardiovasc Dis 17 (2007) 319-326
21. Bray G.A., Jablonski K.A., Fujimoto W.Y., et al., for the Diabetes Prevention Program Research Group. Relation of central adiposity and body mass index to the development of diabetes in the Diabetes Prevention Program. Am J Clin Nutr 87 (2008) 1212-1218
22. Kvist H., Chowdhury B., Grangard U., et al. Total and visceral adipose-tissue volumes derived from measurements with computed tomography in adult men and women: Predictive equations. Am J Clin Nutr 48 (1988) 1351-1361
23. Albu J.B., Murphy L., Frager D.H., et al. Visceral fat and race-dependent health risks in obese non-diabetic premenopausal women. Diabetes 46 (1997) 456-462
24. Machann J., Thamer C., Schnoedt B., et al. Age and gender related effects on adipose tissue compartments of subjects with increased risk for type 2 diabetes: A whole body MRI/MRS study. MAGMA 18 (2005) 128-137
25. Couillard C., Bergeron N., Prud'homme D., et al. Gender difference in postprandial lipemia: Importance of visceral adipose tissue accumulation. Arterioscler Thromb Vasc Biol 19 (1999) 2448-2455
26. Shen W., Wang Z., Punyanita M., et al. Adipose tissue quantification by imaging methods: A proposed classification. Obes Res 11 (2003) 5-16
27. Machann J., Thamer C., Schnoedt B., et al. Standardized assessment of whole body adipose tissue topography by MRI. J Magn Reson Imaging 21 (2005) 455-462
28. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
29. Grundy S.M., Cleeman J.I., Daniels S.R., et al., for the American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement [published correction appears in Circulation. 2005;112:e297, e298]. Circulation 112 (2005) 2735-2752
30. Alberti K.G., Zimmet P., Shaw J., and for the IDF Epidemiology Task Force Consensus Group. The metabolic syndrome-a new worldwide definition. Lancet 366 (2005) 1059-1062
31. Grundy S.M., Cleeman J.I., Daniels S.R., et al. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Curr Opin Cardiol 21 (2006) 1-6
32. Snijder M.B., Dekker J.M., Visser M., et al. Larger thigh and hip circumferences are associated with better glucose tolerance: The Hoorn study. Obes Res 11 (2003) 104-111
33. Snijder M.B., Dekker J.M., Visser M., et al. Trunk fat and leg fat have independent and opposite associations with fasting and postload glucose levels: The Hoorn study. Diabetes Care 27 (2004) 372-377
34. Krssak M., Falk Petersen K., Dresner A., et al. Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: A 1H NMR spectroscopy study [published correction appears in Diabetologia. 1999;42:386]. Diabetologia 42 (1999) 113-116
35. Kelley D.E., Thaete F.L., Troost F., et al. Subdivisions of subcutaneous abdominal adipose tissue and insulin resistance. Am J Physiol Endocrinol Metab 278 (2000) E941-E948
36. Smith S.R., Lovejoy J.C., Greenway F., et al. Contributions of total body fat, abdominal subcutaneous adipose tissue compartments, and visceral adipose tissue to the metabolic complications of obesity. Metabolism 50 (2001) 425-435
37. Misra A., Garg A., Abate N., et al. Relationship of anterior and posterior subcutaneous abdominal fat to insulin sensitivity in nondiabetic men. Obes Res 5 (1997) 93-99
38. Deschenes D., Couture P., Dupont P., and Tchernof A. Subdivision of the subcutaneous adipose tissue compartment and lipid-lipoprotein levels in women. Obes Res 11 (2003) 469-476
39. Nguyen-Duy T.B., Nichaman M.Z., Church T.S., et al. Visceral fat and liver fat are independent predictors of metabolic risk factors in men. Am J Physiol Endocrinol Metab 284 (2003) E1065-E1071
40. Ross R., Aru J., Freeman J., et al. Abdominal adiposity and insulin resistance in obese men. Am J Physiol Endocrinol Metab 282 (2002) E657-E663
41. Lovejoy J.C., Smith S.R., and Rood J.C. Comparison of regional fat distribution and health risk factors in middle-aged white and African American women: The Healthy Transitions Study. Obes Res 9 (2001) 10-16
42. Koska J., Stefan N., Votruba S.B., et al. Distribution of subcutaneous fat predicts insulin action in obesity in sex-specific manner. Obesity (Silver Spring) 16 (2008) 2003-2009
43. Monzon J.R., Basile R., Heneghan S., et al. Lipolysis in adipocytes isolated from deep and superficial subcutaneous adipose tissue. Obes Res 10 (2002) 266-269
44. Enevoldsen L.H., Simonsen L., Stallknecht B., et al. In vivo human lipolytic activity in preperitoneal and subdivisions of subcutaneous abdominal adipose tissue. Am J Physiol Endocrinol Metab 281 (2001) E1110-E1114
45. Kim H.J., Kim H.J., Lee K.E., et al. Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults. Arch Intern Med 164 (2004) 2169-2175
46. Shibata M., Kihara Y., Taguchi M., et al. Nonalcoholic fatty liver disease is a risk factor for type 2 diabetes in middle-aged Japanese men. Diabetes Care 30 (2007) 2940-2944
47. Stefan N., Kantartzis K., and Haring H.U. Causes and metabolic consequences of fatty liver. Endocr Rev 29 (2008) 939-960
48. Kelley D.E., McKolanis T.M., Hegazi R.A., et al. Fatty liver in type 2 diabetes mellitus: Relation to regional adiposity, fatty acids, and insulin resistance. Am J Physiol Endocrinol Metab 285 (2003) E906-E916
49. Thamer C., Machann J., Haap M., et al. Intrahepatic lipids are predicted by visceral adipose tissue mass in healthy subjects. Diabetes Care 27 (2004) 2726-2729
50. Heilbronn L., Smith S.R., and Ravussin E. Failure of fat cell proliferation, mitochondrial function and fat oxidation results in ectopic fat storage, insulin resistance and type II diabetes mellitus. Int J Obes Relat Metab Disord 28 Suppl 4 (2004) S12-S21
51. Trujillo M.E., and Scherer P.E. Adipose tissue-derived factors: Impact on health and disease. Endocr Rev 27 (2006) 762-778
52. Roden M. Mechanisms of disease: Hepatic steatosis in type 2 diabetes-pathogenesis and clinical relevance. Nat Clin Pract Endocrinol Metab 2 (2006) 335-348
53. Kantartzis K., Rittig K., Balletshofer B., et al. The relationships of plasma adiponectin with a favorable lipid profile, decreased inflammation, and less ectopic fat accumulation depend on adiposity. Clin Chem 52 (2006) 1934-1942
54. Bugianesi E., Pagotto U., Manini R., et al. Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity. J Clin Endocrinol Metab 90 (2005) 3498-3504
55. Adiels M., Taskinen M.R., Packard C., et al. Overproduction of large VLDL particles is driven by increased liver fat content in man. Diabetologia 49 (2006) 755-765
56. Moran A., Jacobs Jr. D.R., Steinberger J., et al. Changes in insulin resistance and cardiovascular risk during adolescence: Establishment of differential risk in males and females. Circulation 117 (2008) 2361-2368
57. D'Eon T.M., Souza S.C., Aronovitz M., et al. Estrogen regulation of adiposity and fuel partitioning. Evidence of genomic and non-genomic regulation of lipogenic and oxidative pathways. J Biol Chem 280 (2005) 35983-35991
58. Herrmann B.L., Saller B., Janssen O.E., et al. Impact of estrogen replacement therapy in a male with congenital aromatase deficiency caused by a novel mutation in the CYP19 gene. J Clin Endocrinol Metab 87 (2002) 5476-5484
59. Smith E.P., Boyd J., Frank G.R., et al. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man [published correction appears in N Engl J Med. 1995;332:131]. N Engl J Med 331 (1994) 1056-1061
60. Louet J.F., LeMay C., and Mauvais-Jarvis F. Antidiabetic actions of estrogen: Insight from human and genetic mouse models. Curr Atheroscler Rep 6 (2004) 180-185
61. Rincon J., Holmang A., Wahlstrom E.O., et al. Mechanisms behind insulin resistance in rat skeletal muscle after oophorectomy and additional testosterone treatment. Diabetes 45 (1996) 615-621
62. Matute M.L., and Kalkhoff R.K. Sex steroid influence on hepatic gluconeogenesis and glucogen formation. Endocrinology 92 (1973) 762-768
63. Perrone G., Liu Y., Capri O., et al. Evaluation of the body composition and fat distribution in long-term users of hormone replacement therapy. Gynecol Obstet Invest 48 (1999) 52-55
64. Dantas A.P., and Sandberg K. Estrogen regulation of tumor necrosis factor-alpha: A missing link between menopause and cardiovascular risk in women?. Hypertension 46 (2005) 21-22
65. Carter S., McKenzie S., Mourtzakis M., et al. Short-term 17beta-estradiol decreases glucose R(a) but not whole body metabolism during endurance exercise. J Appl Physiol 90 (2001) 139-146
66. Carter S.L., Rennie C., and Tarnopolsky M.A. Substrate utilization during endurance exercise in men and women after endurance training. Am J Physiol Endocrinol Metab 280 (2001) E898-E907
67. Baba T., Shimizu T., Suzuki Y., et al. Estrogen, insulin, and dietary signals cooperatively regulate longevity signals to enhance resistance to oxidative stress in mice. J Biol Chem 280 (2005) 16417-16426
68. Vina J., Borras C., Gambini J., et al. Why females live longer than males: Control of longevity by sex hormones. Sci Aging Knowledge Environ 17 (2005)
69. Kissebah A.H., and Krakower G.R. Regional adiposity and morbidity. Physiol Rev 74 (1994) 761-811
70. Arenas I.A., Armstrong S.J., Xu Y., and Davidge S.T. Chronic tumor necrosis factor-alpha inhibition enhances NO modulation of vascular function in estrogen-deficient rats. Hypertension 46 (2005) 76-81
71. Pfeilschifter J., Koditz R., Pfohl M., and Schatz H. Changes in proinflammatory cytokine activity after menopause. Endocr Rev 23 (2002) 90-119
72. Steinberg G.R. Inflammation in obesity is the common link between defects in fatty acid metabolism and insulin resistance. Cell Cycle 6 (2007) 888-894
73. Assali A.R., Jabara Z., Shafer Z., et al. Insulin resistance is increased by transdermal estrogen therapy in postmenopausal women with cardiac syndrome X. Cardiology 95 (2001) 31-34
74. Ryan A.S., Nicklas B.J., and Berman D.M. Hormone replacement therapy, insulin sensitivity, and abdominal obesity in postmenopausal women. Diabetes Care 25 (2002) 127-133
75. Friday K.E., Dong C., and Fontenot R.U. Conjugated equine estrogen improves glycemic control and blood lipoproteins in postmenopausal women with type 2 diabetes. J Clin Endocrinol Metab 86 (2001) 48-52
76. Margolis K.L., Bonds D.E., Rodabough R.J., et al., for the Women's Health Initiative Investigators. Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: Results from the Women's Health Initiative Hormone Trial. Diabetologia 47 (2004) 1175-1187
77. Perseghin G., Scifo P., Pagliato E., et al. Gender factors affect fatty acids-induced insulin resistance in nonobese humans: Effects of oral steroidal contraception. J Clin Endocrinol Metab 86 (2001) 3188-3196
78. Spellacy W.N., and Carlson K.L. Plasma insulin and blood glucose levels in patients taking oral contraceptives. A preliminary report of a prospective study. Am J Obstet Gynecol 95 (1966) 474-478
79. Wynn V., and Doar J.W. Some effects of oral contraceptives on carbohydrate metabolism. Lancet 2 (1969) 761-765
80. Wynn V., Doar J.W., and Mills G.L. Some effects of oral contraceptives on serum lipid and lipoprotein levels. Lancet 2 (1966) 799
81. Evans D.J., Hoffmann R.G., Kalkhoff R.K., and Kissebah A.H. Relationship of androgenic activity to body fat topography, fat cell morphology, and metabolic aberrations in premenopausal women. J Clin Endocrinol Metab 57 (1983) 304-310
82. Haffner S.M., Katz M.S., and Dunn J.F. Increased upper body and overall adiposity is associated with decreased sex hormone binding globulin in postmenopausal women. Int J Obes 15 (1991) 471-478
83. Lovejoy J.C., Bray G.A., Bourgeois M.O., et al. Exogenous androgens influence body composition and regional body fat distribution in obese postmenopausal women-a clinical research center study. J Clin Endocrinol Metab 81 (1996) 2198-2203
84. Dunaif A. Hyperandrogenic anovulation (PCOS): A unique disorder of insulin action associated with an increased risk of non-insulin-dependent diabetes mellitus. Am J Med 98 (1995) 33S-39S
85. Polderman K.H., Gooren L.J., Asscheman H., et al. Induction of insulin resistance by androgens and estrogens. J Clin Endocrinol Metab 79 (1994) 265-271
86. Moghetti P., Tosi F., Castello R., et al. The insulin resistance in women with hyperandrogenism is partially reversed by antiandrogen treatment: Evidence that androgens impair insulin action in women. J Clin Endocrinol Metab 81 (1996) 952-960
87. Morimoto S., Fernandez-Mejia C., Romero-Navarro G., et al. Testosterone effect on insulin content, messenger ribonucleic acid levels, promoter activity, and secretion in the rat. Endocrinology 142 (2001) 1442-1447
88. Holmang A., Svedberg J., Jennische E., and Bjorntorp P. Effects of testosterone on muscle insulin sensitivity and morphology in female rats [published correction appears in Am J Physiol. 1993;264:section E]. Am J Physiol 259 (1990) E555-E560
89. Perello M., Castrogiovanni D., Giovambattista A., et al. Impairment in insulin sensitivity after early androgenization in the post-pubertal female rat. Life Sci 80 (2007) 1792-1798
90. Simon D., Charles M.A., Nahoul K., et al. Association between plasma total testosterone and cardiovascular risk factors in healthy adult men: The Telecom Study. J Clin Endocrinol Metab 82 (1997) 682-685
91. Simon D., Charles M.A., Lahlou N., et al. Androgen therapy improves insulin sensitivity and decreases leptin level in healthy adult men with low plasma total testosterone: A 3-month randomized placebo-controlled trial. Diabetes Care 24 (2001) 2149-2151
92. Rebuffe-Scrive M., Marin P., and Bjorntorp P. Effect of testosterone on abdominal adipose tissue in men. Int J Obes 15 (1991) 791-795
93. Haffner S.M., Valdez R.A., Stern M.P., and Katz M.S. Obesity, body fat distribution and sex hormones in men. Int J Obes Relat Metab Disord 17 (1993) 643-649
94. Marin P., Holmang S., Jonsson L., et al. The effects of testosterone treatment on body composition and metabolism in middle-aged obese men. Int J Obes Relat Metab Disord 16 (1992) 991-997
95. Marin P., Holmang S., Gustafsson C., et al. Androgen treatment of abdominally obese men. Obes Res 1 (1993) 245-251
96. Godsland I.F., Shennan N.M., and Wynn V. Insulin action and dynamics modelled in patients taking the anabolic steroid methandienone (Dianabol). Clin Sci (Lond) 71 (1986) 665-673
97. Cohen J.C., and Hickman R. Insulin resistance and diminished glucose tolerance in powerlifters ingesting anabolic steroids. J Clin Endocrinol Metab 64 (1987) 960-963
98. Nishizawa H., Shimomura I., Kishida K., et al. Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes 51 (2002) 2734-2741
99. Belanger C., Luu-The V., Dupont P., and Tchernof A. Adipose tissue intracrinology: Potential importance of local androgen/estrogen metabolism in the regulation of adiposity. Horm Metab Res 34 (2002) 737-745
100. Meseguer A., Puche C., and Cabero A. Sex steroid biosynthesis in white adipose tissue. Horm Metab Res 34 (2002) 731-736
101. Jones M.E., Thorburn A.W., Britt K.L., et al. Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. Proc Natl Acad Sci U S A 97 (2000) 12735-12740
102. Takeda K., Toda K., Saibara T., et al. Progressive development of insulin resistance phenotype in male mice with complete aromatase (CYP19) deficiency. J Endocrinol 176 (2003) 237-246
103. Glass A.R., Swerdloff R.S., Bray G.A., et al. Low serum testosterone and sex-hormone-binding-globulin in massively obese men. J Clin Endocrinol Metab 45 (1977) 1211-1219
104. Kopelman P.G., Pilkington T.R., White N., and Jeffcoate S.L. Abnormal sex steroid secretion and binding in massively obese women. Clin Endocrinol (Oxf) 12 (1980) 363-369
105. Hautanen A. Synthesis and regulation of sex hormone-binding globulin in obesity. Int J Obes Relat Metab Disord 24 Suppl 2 (2000) S64-S70
106. Preziosi P., Barrett-Connor E., Papoz L., et al. Interrelation between plasma sex hormone-binding globulin and plasma insulin in healthy adult women: The telecom study. J Clin Endocrinol Metab 76 (1993) 283-287
107. Birkeland K.I., Hanssen K.F., Torjesen P.A., and Vaaler S. Level of sex hormone-binding globulin is positively correlated with insulin sensitivity in men with type 2 diabetes. J Clin Endocrinol Metab 76 (1993) 275-278
108. Rosner W. The functions of corticosteroid-binding globulin and sex hormone-binding globulin: Recent advances. Endocr Rev 11 (1990) 80-91
109. Lea-Currie Y.R., Wen P., and McIntosh M.K. Dehydroepiandrosterone reduces proliferation and differentiation of 3T3-L1 preadipocytes. Biochem Biophys Res Commun 248 (1998) 497-504
110. De Pergola G., Zamboni M., Sciaraffia M., et al. Body fat accumulation is possibly responsible for lower dehydroepiandrosterone circulating levels in premenopausal obese women. Int J Obes Relat Metab Disord 20 (1996) 1105-1110
111. Hernandez-Morante J.J., Perez-de-Heredia F., Lujan J.A., et al. Role of DHEA-S on body fat distribution: Gender- and depot-specific stimulation of adipose tissue lipolysis. Steroids 73 (2008) 209-215
112. Nestler J.E., Barlascini C.O., Clore J.N., and Blackard W.G. Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men. J Clin Endocrinol Metab 66 (1988) 57-61
113. Mohan P.F., and Cleary M.P. Effect of short-term DHEA administration on liver metabolism of lean and obese rats. Am J Physiol 255 (1988) E1-E8
114. Gottschling-Zeller H., Birgel M., Scriba D., et al. Depot-specific release of leptin from subcutaneous and omental adipocytes in suspension culture: Effect of tumor necrosis factor-alpha and transforming growth factor-beta1. Eur J Endocrinol 141 (1999) 436-442
115. Havel P.J., Kasim-Karakas S., Dubuc G.R., et al. Gender differences in plasma leptin concentrations. Nat Med 2 (1996) 949-950
116. Luukkaa V., Pesonen U., Huhtaniemi I., et al. Inverse correlation between serum testosterone and leptin in men. J Clin Endocrinol Metab 83 (1998) 3243-3246
117. Haffner S.M., Miettinen H., Karhapaa P., et al. Leptin concentrations, sex hormones, and cortisol in nondiabetic men. J Clin Endocrinol Metab 82 (1997) 1807-1809
118. Margetic S., Gazzola C., Pegg G.G., and Hill R.A. Leptin: A review of its peripheral actions and interactions. Int J Obes Relat Metab Disord 26 (2002) 1407-1433
119. Van Harmelen V., Reynisdottir S., Eriksson P., et al. Leptin secretion from subcutaneous and visceral adipose tissue in women. Diabetes 47 (1998) 913-917
120. Bennett F.I., McFarlane-Anderson N., Wilks R., et al. Leptin concentration in women is influenced by regional distribution of adipose tissue. Am J Clin Nutr 66 (1997) 1340-1344
121. Flier J.S. Clinical review 94: What's in a name? In search of leptin's physiologic role. J Clin Endocrinol Metab 83 (1998) 1407-1413
122. Flier J.S. Obesity wars: Molecular progress confronts an expanding epidemic. Cell 116 (2004) 337-350
123. Diez J.J., and Iglesias P. The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Endocrinol 148 (2003) 293-300
124. Motoshima H., Wu X., Sinha M.K., et al. Differential regulation of adiponectin secretion from cultured human omental and subcutaneous adipocytes: Effects of insulin and rosiglitazone. J Clin Endocrinol Metab 87 (2002) 5662-5667
125. Batterham R.L., Cowley M.A., Small C.J., et al. Gut hormone PYY(3-36) physiologically inhibits food intake. Nature 418 (2002) 650-654
126. Yamauchi T., Kamon J., Waki H., et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7 (2001) 941-946
127. Cnop M., Havel P.J., Utzschneider K.M., et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: Evidence for independent roles of age and sex. Diabetologia 46 (2003) 459-469
128. Salas-Salvado J., Granada M., Bullo M., et al. Plasma adiponectin distribution in a Mediterranean population and its association with cardiovascular risk factors and metabolic syndrome. Metabolism 56 (2007) 1486-1492
129. Paul D.R., Novotny J.A., and Rumpler W.V. Effects of the interaction of sex and food intake on the relation between energy expenditure and body composition. Am J Clin Nutr 79 (2004) 385-389
130. Gallagher D., Belmonte D., Deurenberg P., et al. Organ-tissue mass measurement allows modeling of REE and metabolically active tissue mass. Am J Physiol 275 (1998) E249-E258
131. Johnstone A.M., Murison S.D., Duncan J.S., et al. Factors influencing variation in basal metabolic rate include fat-free mass, fat mass, age, and circulating thyroxine but not sex, circulating leptin, or triiodothyronine. Am J Clin Nutr 82 (2005) 941-948
132. Shen W., Punyanitya M., Wang Z., et al. Total body skeletal muscle and adipose tissue volumes: Estimation from a single abdominal cross-sectional image. J Appl Physiol 97 (2004) 2333-2338
133. Donnelly J.E., Hill J.O., Jacobsen D.J., et al. Effects of a 16-month randomized controlled exercise trial on body weight and composition in young, over-weight men and women: The Midwest Exercise Trial. Arch Intern Med 163 (2003) 1343-1350
134. Westerterp K.R., and Goran M.I. Relationship between physical activity related energy expenditure and body composition: A gender difference. Int J Obes Relat Metab Disord 21 (1997) 184-188
135. Stubbs R.J., Sepp A., Hughes D.A., et al. The effect of graded levels of exercise on energy intake and balance in free-living men, consuming their normal diet. Eur J Clin Nutr 56 (2002) 129-140
136. Stubbs R.J., Sepp A., Hughes D.A., et al. The effect of graded levels of exercise on energy intake and balance in free-living women. Int J Obes Relat Metab Disord 26 (2002) 866-869
137. McLaughlin R., Malkova D., and Nimmo M.A. Spontaneous activity responses to exercise in males and females. Eur J Clin Nutr 60 (2006) 1055-1061
138. Cohn J.S., McNamara J.R., Cohn S.D., et al. Post-prandial plasma lipoprotein changes in human subjects of different ages. J Lipid Res 29 (1988) 469-479
139. Matikainen N., Manttari S., Westerbacka J., et al. Postprandial lipemia associates with liver fat content. J Clin Endocrinol Metab 92 (2007) 3052-3059
140. Nimitphong H., Phongkitkarun S., Rattarasarn C., et al. Hepatic fat content is a determinant of postprandial triglyceride levels in type 2 diabetes mellitus patients with normal fasting triglyceride. Metabolism 57 (2008) 644-649
141. Godsland I.F., Wynn V., Crook D., and Miller N.E. Sex, plasma lipoproteins, and atherosclerosis: Prevailing assumptions and outstanding questions. Am Heart J 114 (1987) 1467-1503
142. Westerveld H.T., Meyer E., de Bruin T.W., and Erkelens D.W. Oestrogens and postprandial lipid metabolism. Biochem Soc Trans 25 (1997) 45-49
143. Kojima M., Hosoda H., Date Y., et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402 (1999) 656-660
144. Date Y., Kojima M., Hosoda H., et al. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology 141 (2000) 4255-4261
145. Cummings D.E., Purnell J.Q., Frayo R.S., et al. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 50 (2001) 1714-1719
146. English P.J., Ghatei M.A., Malik I.A., et al. Food fails to suppress ghrelin levels in obese humans. J Clin Endocrinol Metab 87 (2002) 2984
147. McCowen K.C., Maykel J.A., Bistrian B.R., and Ling P.R. Circulating ghrelin concentrations are lowered by intravenous glucose or hyperinsulinemic euglycemic conditions in rodents. J Endocrinol 175 (2002) R7-R11
148. Mohlig M., Spranger J., Otto B., et al. Euglycemic hyperinsulinemia, but not lipid infusion, decreases circulating ghrelin levels in humans. J Endocrinol Invest 25 (2002) RC36-RC38
149. Saad M.F., Bernaba B., Hwu C.M., et al. Insulin regulates plasma ghrelin concentration. J Clin Endocrinol Metab 87 (2002) 3997-4000
150. Flanagan D.E., Evans M.L., Monsod T.P., et al. The influence of insulin on circulating ghrelin. Am J Physiol Endocrinol Metab 284 (2003) E313-E316
151. Schaller G., Schmidt A., Pleiner J., et al. Plasma ghrelin concentrations are not regulated by glucose or insulin: A double-blind, placebo-controlled crossover clamp study. Diabetes 52 (2003) 16-20
152. Caixas A., Bashore C., Nash W., et al. Insulin, unlike food intake, does not suppress ghrelin in human subjects. J Clin Endocrinol Metab 87 (2002) 1902
153. Barkan A.L., Dimaraki E.V., Jessup S.K., et al. Ghrelin secretion in humans is sexually dimorphic, suppressed by somatostatin, and not affected by the ambient growth hormone levels. J Clin Endocrinol Metab 88 (2003) 2180-2184
154. Greenman Y., Golani N., Gilad S., et al. Ghrelin secretion is modulated in a nutrient- and gender-specific manner. Clin Endocrinol (Oxf) 60 (2004) 382-388
155. Purnell J.Q., Weigle D.S., Breen P., and Cummings D.E. Ghrelin levels correlate with insulin levels, insulin resistance, and high-density lipoprotein cholesterol, but not with gender, menopausal status, or cortisol levels in humans. J Clin Endocrinol Metab 88 (2003) 5747-5752
156. Tschop M., Weyer C., Tataranni P.A., et al. Circulating ghrelin levels are decreased in human obesity. Diabetes 50 (2001) 707-709